7 September 2023
SHARE NOW
ATE
Cell Therapy
Finance & Investment
Gene Therapy
Strategy
Benoit Champluvier kicks off this session on innovative technologies as a driver of European cell and gene therapy commercialization & successful market adoption
During this session, Benoit Champluvier, Head of Pharmaceutical Development, Sangamo Therapeutics France is joined by Avencia Sanchez-Mejias, Co-Founder & Chief Executive Officer, Integra Therapeutics, Paula Pulsoni, Vice President, Sales and Services, WorldCourier, Ricardo Baptista, Chief Technology Officer, Alder Therapeutics AB and Angelo Raggioli, Head of Technology Development, ReiThera.
This Session was recorded at Advanced Therapies Europe 2023.
More like this
Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing
Are you looking for a cost-effective, high-productivity extracellular vesicle (EV) production platform that overcomes traditional manufacturing challenges? Join us to discover how Univercells Technologies’ scalable fixed-bed design is transforming EV manufacturing.
14 May 2024
Women in Advanced Therapies Global 2024, Virtual Event
Experience Women in Advanced Therapies Global, a 24-hour online event uniting the community in celebration of inspiration, innovation, and empowerment. Access exclusive insights, workshops, and networking opportunities from anywhere.
8 April 2024
